NIIMBL funds new biopharmaceutical manufacturing projects

By The Science Advisory Board staff writers

May 20, 2020 -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that it is funding 14 new projects in technology, workforce development, and the Global Health Fund initiative, amounting to approximately $10 million.

The projects were selected from the institute's Project Call 3.1 as a means to drive innovation and advancement for the biopharmaceutical industry. The projects will address technology areas including process analytical technologies for contamination detection, cell therapy manufacturing processes, single-use components for continuous manufacturing, and data analytics applications in biomanufacturing.

Workforce development projects will offer new skills for incumbent workers in the cell therapy field, provide new career avenues for military members, and pilot an industry-academia hybrid virtual-based training program.

Two of the projects will be part of the Global Health Fund in partnership with the Bill and Melinda Gates Foundation. They will explore technologies that reduce animal-based testing and improve vaccine manufacturing processes.

Since its launch in 2017, NIIMBL has contributed over $63 million to the industry and contributed to over 70 technology and workforce development programs. NIIMBL has made the award details and participants available online.

Copyright © 2020

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.